Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025

Q3 FY24 results · Oct–Dec 2023

Advanced Enzyme Technologies reported revenue from operations of ₹160.94 crore (up 13.2% from Q3 FY23) and net profit of ₹42.50 crore (up 52.3% from Q3 FY23) for Q3 FY24 (Oct–Dec 2023), on a consolidated basis.

Consolidated · ₹ crore
ItemQ3 FY24Q3 FY23YoYQ2 FY24QoQ
Revenue from operations160.94142.11+13.2%157.84+2.0%
Other income14.408.52+69.1%6.09+136.2%
Total income175.33150.63+16.4%163.94+7.0%
Profit before tax58.8840.45+45.5%47.93+22.8%
Net profit for the period42.5027.91+52.3%35.20+20.8%
Attributable to shareholders of the company41.7729.44+41.9%34.41+21.4%
EPS, basic (₹)3.742.63+42.2%3.08+21.4%
Net margin (%)26.419.622.3
Standalone · ₹ crore
ItemQ3 FY24Q3 FY23YoYQ2 FY24QoQ
Revenue from operations91.1479.68+14.4%96.58−5.6%
Other income3.563.75−5.0%0.79+354.1%
Total income94.7183.44+13.5%97.36−2.7%
Profit before tax25.3622.31+13.6%24.76+2.4%
Net profit for the period19.1216.64+14.9%18.38+4.0%
EPS, basic (₹)1.711.49+14.8%1.64+4.3%
Net margin (%)21.020.919.0
Consolidated
Filed with BSE
22 Feb 2024, 14:27 IST
Board meeting
10 Feb 2024
Period
01 Oct 2023 to 31 Dec 2023
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
22 Feb 2024, 14:27 IST
Board meeting
10 Feb 2024
Period
01 Oct 2023 to 31 Dec 2023
Review status
Unaudited
Source
XBRL filing on BSE